About: Alessio Cortellini

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Alessio Cortellini Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher ORCID ID = 0000-0002-1209-5735

Attributes	Values
rdf:type	Item
description	forskare (sv) изилдөөчү (ky) onderzoeker (nl) researcher ORCID ID = 0000-0002-1209-5735 (en)
rdfs:label	Alessio Cortellini (en) Alessio Cortellini (es) Alessio Cortellini (it) Alessio Cortellini (nl) Alessio Cortellini (ast)
skos:prefLabel	Alessio Cortellini (en) Alessio Cortellini (es) Alessio Cortellini (it) Alessio Cortellini (nl) Alessio Cortellini (ast)
name	Alessio Cortellini (en) Alessio Cortellini (es) Alessio Cortellini (it) Alessio Cortellini (nl) Alessio Cortellini (ast)
Scopus author ID	wds:Q61163171-5BC45A52-B1CE-4C54-8184-63199C4F5B5B
Scopus author ID	57195202998
given name	wds:Q61163171-38F3E6CD-A77A-4ACE-B46F-A9C882219158
given name	Alessio
instance of	wds:Q61163171-E5BA3D18-A6AD-4FC0-BF78-FAE91AC160D0
instance of	Homo sapiens
occupation	wds:Q61163171-1C3A3317-1D18-48A6-9DC7-755C071B105D
employer	wds:Q61163171-B6F5E845-7895-4D16-8C00-B0CA8A6F831B wds:Q61163171-F400F7A3-FF3A-45F2-B9F7-8AD1E62FAE85
sex or gender	wds:Q61163171-2EA86D37-FBA1-4D14-A016-AFFFA5872E67
educated at	wds:Q61163171-8EAB89AF-E8EC-4AFA-995D-0436F8E7AE46 wds:Q61163171-A1654FCE-8600-40B3-915B-196C5EA05B0D
family name	wds:Q61163171-40743097-730B-4CC9-B21A-9EAC256821E3
occupation	researcher
employer	Imperial College London San Salvatore Hospital
sex or gender	male
educated at	University of L'Aquila
family name	Cortellini
ORCID iD	wds:Q61163171-4176730F-4CE6-4783-9CCC-42214C5EDA16
Dimensions author ID	wds:Q61163171-11B2E6BC-DA34-4823-A5AC-076A00EF54FA
ORCID iD	https://orcid.org/0000-0002-1209-5735
ORCID iD	0000-0002-1209-5735
Dimensions author ID	016453317427.19
IRIS UNIVAQ author ID	wds:Q61163171-68969A22-2D67-4C41-983B-90F6D2DE13EC
IRIS UNIVAQ author ID	05661
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q61163171
is author of	Early prediction of resistance to tyrosine kinase inhibitors by plasma monitoring of EGFR mutations in NSCLC: a new algorithm for patient selection and personalized treatment Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice Home care for cancer patients during COVID-19 pandemic: the "double triage" protocol Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-r Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study Topical Menthol for Treatment of Chemotherapy-induced Peripheral Neuropathy. A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable Family history of cancer as surrogate predictor for immunotherapy with anti-PD1/PD-L1 agents: preliminary report of the FAMI-L1 study Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study Are anti-PD1 and anti-PD-L1 alike? The non-small-cell lung cancer paradigm The way towards tailored treatment for metastatic renal cancer patients in the omics era: are we getting a "transcriptomic compass"? Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians' attitudes TERAVOLT: Thoracic Cancers International COVID-19 Collaboration First-line carboplatin/nab-paclitaxel in advanced ovarian cancer patients, after hypersensitivity reaction to solvent-based taxanes: a single-institution experience Family History of Cancer as Potential Prognostic Factor in Stage III Colorectal Cancer: a Retrospective Monoinstitutional Study Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50 COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study Preliminary results from a phase Ib study of neoadjuvant ipilimumab plus nivolumab prior to liver resection for hepatocellular carcinoma: The PRIME-HCC trial. INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study "Vessels in the Storm": Searching for Prognostic and Predictive Angiogenic Factors in Colorectal Cancer. Author Correction: Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients Expression of pro-angiogenic factors as potential biomarkers in experimental models of colon cancer Cancer Care After Natural Disaster: Different Countries, Similar Problems Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving Nivolumab Intra-patient Heterogeneity of BRAF and NRAS Molecular Alterations in Primary Melanoma and Metastases Family history of cancer and DNA damage response genes: Two sides of the same coin? Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non-small cell lung cancer patients: A "hypothesis-generator" preliminary report Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes Single-institution study of correlations between skeletal muscle mass, its density, and clinical outcomes in non-small cell lung cancer patients treated with first-line chemotherapy What cancer patients actually know regarding medical cannabis? A cross-sectional survey with a critical analysis of the current attitudes Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: a retrospective multicenter study Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival Looking for A Place for Dose-Dense TMZ Regimens in GBM Patients: An Experience with MGMT Exploratory Evaluation Immunological insights on influenza infection and vaccination during immune checkpoint blockade in cancer patients Immune context characterization and heterogeneity in primary tumors and pulmonary metastases from renal cell carcinoma A systematic review on the emerging association between the occurrence of immune-related adverse events and clinical outcomes with checkpoint inhibitors in advanced cancer patients Unlocking the secret of the obesity paradox in renal tumours Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients Immune Checkpoint Inhibitors and Myasthenic Syndromes: A Case Report of a Metastatic Renal Cell Carcinoma Patient Treated With Nivolumab Haloperidol for the treatment of opioid addiction in advanced cancer patients: a case series The Agnostic Role of Site of Metastasis in Predicting Outcomes in Cancer Patients Treated with Immunotherapy Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study KRAS and Two Rare PI3KCA Mutations Coexisting in a Metastatic Colorectal Cancer Patient With Aggressive and Resistant Disease. Evaluation of Prognostic Factors for Survival in Transverse Colon Cancer Palliative radiotherapy in advanced cancer patients treated with immune-checkpoint inhibitors: The PRACTICE study PRIME-HCC: phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinoma COVID-19 Pneumonia and Immune-Related Pneumonitis: critical issues on differential diagnosis, potential interactions and management Impact of influenza syndrome and flu vaccine on survival of cancer patients during immunotherapy in the INVIDIa study Timed‑flat infusion of 5‑fluorouracil with docetaxel and oxaliplatin as first‑line treatment of gastroesophageal adenocarcinoma: A single institution experience with the FD/FOx regimen Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software